Global Infectious Disease In Vitro Diagnostics Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global industry is witnessing growth due to the factors, such as the growing geriatric population susceptible to infectious diseases, high demand for PoC testing owing to the pandemic, rising awareness about early testing, and rising prevalence of infectious diseases.
The global market for Infectious Disease In Vitro Diagnostics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Infectious Disease In Vitro Diagnostics players cover QIAGEN, BD, bioM?rieux SA, F. Hoffmann-La Roche, Ltd. and Hologic, Inc. (Gen-Probe), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Infectious Disease In Vitro Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Infectious Disease In Vitro Diagnostics market, with both quantitative and qualitative data, to help readers understand how the Infectious Disease In Vitro Diagnostics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Infectious Disease In Vitro Diagnostics market and forecasts the market size by Type (Instruments and Reagents,), by Application (Hospitals & Clinics, Diagnostic Laboratories and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Infectious Disease In Vitro Diagnostics, Research Methodology, etc.
Chapter 2: Executive Summary, global Infectious Disease In Vitro Diagnostics market size and CAGR, Infectious Disease In Vitro Diagnostics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Infectious Disease In Vitro Diagnostics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Infectious Disease In Vitro Diagnostics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Infectious Disease In Vitro Diagnostics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including QIAGEN, BD, bioM?rieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG and Bio-Rad Laboratories, Inc., etc.
Chapter 14: Research Findings and Conclusion
The global industry is witnessing growth due to the factors, such as the growing geriatric population susceptible to infectious diseases, high demand for PoC testing owing to the pandemic, rising awareness about early testing, and rising prevalence of infectious diseases.
The global market for Infectious Disease In Vitro Diagnostics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Infectious Disease In Vitro Diagnostics players cover QIAGEN, BD, bioM?rieux SA, F. Hoffmann-La Roche, Ltd. and Hologic, Inc. (Gen-Probe), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Infectious Disease In Vitro Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Infectious Disease In Vitro Diagnostics market, with both quantitative and qualitative data, to help readers understand how the Infectious Disease In Vitro Diagnostics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Infectious Disease In Vitro Diagnostics market and forecasts the market size by Type (Instruments and Reagents,), by Application (Hospitals & Clinics, Diagnostic Laboratories and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Instruments
- Reagents
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- QIAGEN
- BD
- bioM?rieux SA
- F. Hoffmann-La Roche, Ltd.
- Hologic, Inc. (Gen-Probe)
- Abbott
- Quidel Corp.
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Danaher Corp.
- OraSure Technologies, Inc.
Chapter 1: Scope of Infectious Disease In Vitro Diagnostics, Research Methodology, etc.
Chapter 2: Executive Summary, global Infectious Disease In Vitro Diagnostics market size and CAGR, Infectious Disease In Vitro Diagnostics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Infectious Disease In Vitro Diagnostics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Infectious Disease In Vitro Diagnostics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Infectious Disease In Vitro Diagnostics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including QIAGEN, BD, bioM?rieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG and Bio-Rad Laboratories, Inc., etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease In Vitro Diagnostics Market Size 2017-2028
2.1.2 Infectious Disease In Vitro Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Infectious Disease In Vitro Diagnostics Segment by Type
2.2.1 Instruments
2.2.2 Reagents
2.3 Infectious Disease In Vitro Diagnostics Market Size by Type
2.3.1 Infectious Disease In Vitro Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Infectious Disease In Vitro Diagnostics Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 Infectious Disease In Vitro Diagnostics Market Size by Application
2.5.1 Infectious Disease In Vitro Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
3 INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Infectious Disease In Vitro Diagnostics Market Size Market Share by Players
3.1.1 Global Infectious Disease In Vitro Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Infectious Disease In Vitro Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE IN VITRO DIAGNOSTICS BY REGIONS
4.1 Infectious Disease In Vitro Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
4.3 APAC Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
4.4 Europe Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Infectious Disease In Vitro Diagnostics Market Size by Country (2017-2022)
5.2 Americas Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
5.3 Americas Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease In Vitro Diagnostics Market Size by Region (2017-2022)
6.2 APAC Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
6.3 APAC Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease In Vitro Diagnostics by Country (2017-2022)
7.2 Europe Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
7.3 Europe Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease In Vitro Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET FORECAST
10.1 Global Infectious Disease In Vitro Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Infectious Disease In Vitro Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Infectious Disease In Vitro Diagnostics Forecast
10.1.3 APAC Infectious Disease In Vitro Diagnostics Forecast
10.1.4 Europe Infectious Disease In Vitro Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Forecast
10.2 Americas Infectious Disease In Vitro Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Infectious Disease In Vitro Diagnostics Market Forecast
10.2.2 Canada Infectious Disease In Vitro Diagnostics Market Forecast
10.2.3 Mexico Infectious Disease In Vitro Diagnostics Market Forecast
10.2.4 Brazil Infectious Disease In Vitro Diagnostics Market Forecast
10.3 APAC Infectious Disease In Vitro Diagnostics Forecast by Region (2023-2028)
10.3.1 China Infectious Disease In Vitro Diagnostics Market Forecast
10.3.2 Japan Infectious Disease In Vitro Diagnostics Market Forecast
10.3.3 Korea Infectious Disease In Vitro Diagnostics Market Forecast
10.3.4 Southeast Asia Infectious Disease In Vitro Diagnostics Market Forecast
10.3.5 India Infectious Disease In Vitro Diagnostics Market Forecast
10.3.6 Australia Infectious Disease In Vitro Diagnostics Market Forecast
10.4 Europe Infectious Disease In Vitro Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Infectious Disease In Vitro Diagnostics Market Forecast
10.4.2 France Infectious Disease In Vitro Diagnostics Market Forecast
10.4.3 UK Infectious Disease In Vitro Diagnostics Market Forecast
10.4.4 Italy Infectious Disease In Vitro Diagnostics Market Forecast
10.4.5 Russia Infectious Disease In Vitro Diagnostics Market Forecast
10.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Infectious Disease In Vitro Diagnostics Market Forecast
10.5.2 South Africa Infectious Disease In Vitro Diagnostics Market Forecast
10.5.3 Israel Infectious Disease In Vitro Diagnostics Market Forecast
10.5.4 Turkey Infectious Disease In Vitro Diagnostics Market Forecast
10.5.5 GCC Countries Infectious Disease In Vitro Diagnostics Market Forecast
10.6 Global Infectious Disease In Vitro Diagnostics Forecast by Type (2023-2028)
10.7 Global Infectious Disease In Vitro Diagnostics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Infectious Disease In Vitro Diagnostics Product Offered
11.1.3 QIAGEN Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Infectious Disease In Vitro Diagnostics Product Offered
11.2.3 BD Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 bioM?rieux SA
11.3.1 bioM?rieux SA Company Information
11.3.2 bioM?rieux SA Infectious Disease In Vitro Diagnostics Product Offered
11.3.3 bioM?rieux SA Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 bioM?rieux SA Main Business Overview
11.3.5 bioM?rieux SA Latest Developments
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Information
11.4.2 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Product Offered
11.4.3 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 F. Hoffmann-La Roche, Ltd. Main Business Overview
11.4.5 F. Hoffmann-La Roche, Ltd. Latest Developments
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Information
11.5.2 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Product Offered
11.5.3 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Hologic, Inc. (Gen-Probe) Main Business Overview
11.5.5 Hologic, Inc. (Gen-Probe) Latest Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott Infectious Disease In Vitro Diagnostics Product Offered
11.6.3 Abbott Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Abbott Main Business Overview
11.6.5 Abbott Latest Developments
11.7 Quidel Corp.
11.7.1 Quidel Corp. Company Information
11.7.2 Quidel Corp. Infectious Disease In Vitro Diagnostics Product Offered
11.7.3 Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Quidel Corp. Main Business Overview
11.7.5 Quidel Corp. Latest Developments
11.8 Siemens Healthineers AG
11.8.1 Siemens Healthineers AG Company Information
11.8.2 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Product Offered
11.8.3 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Siemens Healthineers AG Main Business Overview
11.8.5 Siemens Healthineers AG Latest Developments
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Information
11.9.2 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Product Offered
11.9.3 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.9.5 Bio-Rad Laboratories, Inc. Latest Developments
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Information
11.10.2 Danaher Corp. Infectious Disease In Vitro Diagnostics Product Offered
11.10.3 Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Danaher Corp. Main Business Overview
11.10.5 Danaher Corp. Latest Developments
11.11 OraSure Technologies, Inc.
11.11.1 OraSure Technologies, Inc. Company Information
11.11.2 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Product Offered
11.11.3 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 OraSure Technologies, Inc. Main Business Overview
11.11.5 OraSure Technologies, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease In Vitro Diagnostics Market Size 2017-2028
2.1.2 Infectious Disease In Vitro Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Infectious Disease In Vitro Diagnostics Segment by Type
2.2.1 Instruments
2.2.2 Reagents
2.3 Infectious Disease In Vitro Diagnostics Market Size by Type
2.3.1 Infectious Disease In Vitro Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Infectious Disease In Vitro Diagnostics Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 Infectious Disease In Vitro Diagnostics Market Size by Application
2.5.1 Infectious Disease In Vitro Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
3 INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Infectious Disease In Vitro Diagnostics Market Size Market Share by Players
3.1.1 Global Infectious Disease In Vitro Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Infectious Disease In Vitro Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE IN VITRO DIAGNOSTICS BY REGIONS
4.1 Infectious Disease In Vitro Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
4.3 APAC Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
4.4 Europe Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Infectious Disease In Vitro Diagnostics Market Size by Country (2017-2022)
5.2 Americas Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
5.3 Americas Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease In Vitro Diagnostics Market Size by Region (2017-2022)
6.2 APAC Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
6.3 APAC Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease In Vitro Diagnostics by Country (2017-2022)
7.2 Europe Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
7.3 Europe Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease In Vitro Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET FORECAST
10.1 Global Infectious Disease In Vitro Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Infectious Disease In Vitro Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Infectious Disease In Vitro Diagnostics Forecast
10.1.3 APAC Infectious Disease In Vitro Diagnostics Forecast
10.1.4 Europe Infectious Disease In Vitro Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Forecast
10.2 Americas Infectious Disease In Vitro Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Infectious Disease In Vitro Diagnostics Market Forecast
10.2.2 Canada Infectious Disease In Vitro Diagnostics Market Forecast
10.2.3 Mexico Infectious Disease In Vitro Diagnostics Market Forecast
10.2.4 Brazil Infectious Disease In Vitro Diagnostics Market Forecast
10.3 APAC Infectious Disease In Vitro Diagnostics Forecast by Region (2023-2028)
10.3.1 China Infectious Disease In Vitro Diagnostics Market Forecast
10.3.2 Japan Infectious Disease In Vitro Diagnostics Market Forecast
10.3.3 Korea Infectious Disease In Vitro Diagnostics Market Forecast
10.3.4 Southeast Asia Infectious Disease In Vitro Diagnostics Market Forecast
10.3.5 India Infectious Disease In Vitro Diagnostics Market Forecast
10.3.6 Australia Infectious Disease In Vitro Diagnostics Market Forecast
10.4 Europe Infectious Disease In Vitro Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Infectious Disease In Vitro Diagnostics Market Forecast
10.4.2 France Infectious Disease In Vitro Diagnostics Market Forecast
10.4.3 UK Infectious Disease In Vitro Diagnostics Market Forecast
10.4.4 Italy Infectious Disease In Vitro Diagnostics Market Forecast
10.4.5 Russia Infectious Disease In Vitro Diagnostics Market Forecast
10.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Infectious Disease In Vitro Diagnostics Market Forecast
10.5.2 South Africa Infectious Disease In Vitro Diagnostics Market Forecast
10.5.3 Israel Infectious Disease In Vitro Diagnostics Market Forecast
10.5.4 Turkey Infectious Disease In Vitro Diagnostics Market Forecast
10.5.5 GCC Countries Infectious Disease In Vitro Diagnostics Market Forecast
10.6 Global Infectious Disease In Vitro Diagnostics Forecast by Type (2023-2028)
10.7 Global Infectious Disease In Vitro Diagnostics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Infectious Disease In Vitro Diagnostics Product Offered
11.1.3 QIAGEN Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Infectious Disease In Vitro Diagnostics Product Offered
11.2.3 BD Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 bioM?rieux SA
11.3.1 bioM?rieux SA Company Information
11.3.2 bioM?rieux SA Infectious Disease In Vitro Diagnostics Product Offered
11.3.3 bioM?rieux SA Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 bioM?rieux SA Main Business Overview
11.3.5 bioM?rieux SA Latest Developments
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Information
11.4.2 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Product Offered
11.4.3 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 F. Hoffmann-La Roche, Ltd. Main Business Overview
11.4.5 F. Hoffmann-La Roche, Ltd. Latest Developments
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Information
11.5.2 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Product Offered
11.5.3 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Hologic, Inc. (Gen-Probe) Main Business Overview
11.5.5 Hologic, Inc. (Gen-Probe) Latest Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott Infectious Disease In Vitro Diagnostics Product Offered
11.6.3 Abbott Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Abbott Main Business Overview
11.6.5 Abbott Latest Developments
11.7 Quidel Corp.
11.7.1 Quidel Corp. Company Information
11.7.2 Quidel Corp. Infectious Disease In Vitro Diagnostics Product Offered
11.7.3 Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Quidel Corp. Main Business Overview
11.7.5 Quidel Corp. Latest Developments
11.8 Siemens Healthineers AG
11.8.1 Siemens Healthineers AG Company Information
11.8.2 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Product Offered
11.8.3 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Siemens Healthineers AG Main Business Overview
11.8.5 Siemens Healthineers AG Latest Developments
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Information
11.9.2 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Product Offered
11.9.3 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.9.5 Bio-Rad Laboratories, Inc. Latest Developments
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Information
11.10.2 Danaher Corp. Infectious Disease In Vitro Diagnostics Product Offered
11.10.3 Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Danaher Corp. Main Business Overview
11.10.5 Danaher Corp. Latest Developments
11.11 OraSure Technologies, Inc.
11.11.1 OraSure Technologies, Inc. Company Information
11.11.2 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Product Offered
11.11.3 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 OraSure Technologies, Inc. Main Business Overview
11.11.5 OraSure Technologies, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Disease In Vitro Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Instruments
Table 3. Major Players of Reagents
Table 4. Infectious Disease In Vitro Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 7. Infectious Disease In Vitro Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 10. Global Infectious Disease In Vitro Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Player (2020-2022)
Table 12. Infectious Disease In Vitro Diagnostics Key Players Head office and Products Offered
Table 13. Infectious Disease In Vitro Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Infectious Disease In Vitro Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Infectious Disease In Vitro Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Infectious Disease In Vitro Diagnostics Market Size Market Share by Country (2017-2022)
Table 20. Americas Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 22. Americas Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 24. APAC Infectious Disease In Vitro Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Region (2017-2022)
Table 26. APAC Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 28. APAC Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 30. Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Country (2017-2022)
Table 32. Europe Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 34. Europe Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Infectious Disease In Vitro Diagnostics
Table 43. Key Market Challenges & Risks of Infectious Disease In Vitro Diagnostics
Table 44. Key Industry Trends of Infectious Disease In Vitro Diagnostics
Table 45. Global Infectious Disease In Vitro Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Infectious Disease In Vitro Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Infectious Disease In Vitro Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Infectious Disease In Vitro Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Infectious Disease In Vitro Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Infectious Disease In Vitro Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 51. QIAGEN Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 52. QIAGEN Infectious Disease In Vitro Diagnostics Product Offered
Table 53. QIAGEN Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. QIAGEN Main Business
Table 55. QIAGEN Latest Developments
Table 56. BD Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 57. BD Infectious Disease In Vitro Diagnostics Product Offered
Table 58. BD Main Business
Table 59. BD Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. BD Latest Developments
Table 61. bioM?rieux SA Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 62. bioM?rieux SA Infectious Disease In Vitro Diagnostics Product Offered
Table 63. bioM?rieux SA Main Business
Table 64. bioM?rieux SA Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. bioM?rieux SA Latest Developments
Table 66. F. Hoffmann-La Roche, Ltd. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 67. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Product Offered
Table 68. F. Hoffmann-La Roche, Ltd. Main Business
Table 69. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. F. Hoffmann-La Roche, Ltd. Latest Developments
Table 71. Hologic, Inc. (Gen-Probe) Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 72. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Product Offered
Table 73. Hologic, Inc. (Gen-Probe) Main Business
Table 74. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Hologic, Inc. (Gen-Probe) Latest Developments
Table 76. Abbott Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 77. Abbott Infectious Disease In Vitro Diagnostics Product Offered
Table 78. Abbott Main Business
Table 79. Abbott Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Abbott Latest Developments
Table 81. Quidel Corp. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 82. Quidel Corp. Infectious Disease In Vitro Diagnostics Product Offered
Table 83. Quidel Corp. Main Business
Table 84. Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Quidel Corp. Latest Developments
Table 86. Siemens Healthineers AG Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 87. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Product Offered
Table 88. Siemens Healthineers AG Main Business
Table 89. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Siemens Healthineers AG Latest Developments
Table 91. Bio-Rad Laboratories, Inc. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 92. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Product Offered
Table 93. Bio-Rad Laboratories, Inc. Main Business
Table 94. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bio-Rad Laboratories, Inc. Latest Developments
Table 96. Danaher Corp. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 97. Danaher Corp. Infectious Disease In Vitro Diagnostics Product Offered
Table 98. Danaher Corp. Main Business
Table 99. Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Danaher Corp. Latest Developments
Table 101. OraSure Technologies, Inc. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 102. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Product Offered
Table 103. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. OraSure Technologies, Inc. Main Business
Table 105. OraSure Technologies, Inc. Latest Developments
Table 1. Infectious Disease In Vitro Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Instruments
Table 3. Major Players of Reagents
Table 4. Infectious Disease In Vitro Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 7. Infectious Disease In Vitro Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 10. Global Infectious Disease In Vitro Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Player (2020-2022)
Table 12. Infectious Disease In Vitro Diagnostics Key Players Head office and Products Offered
Table 13. Infectious Disease In Vitro Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Infectious Disease In Vitro Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Infectious Disease In Vitro Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Infectious Disease In Vitro Diagnostics Market Size Market Share by Country (2017-2022)
Table 20. Americas Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 22. Americas Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 24. APAC Infectious Disease In Vitro Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Region (2017-2022)
Table 26. APAC Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 28. APAC Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 30. Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Country (2017-2022)
Table 32. Europe Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 34. Europe Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Infectious Disease In Vitro Diagnostics
Table 43. Key Market Challenges & Risks of Infectious Disease In Vitro Diagnostics
Table 44. Key Industry Trends of Infectious Disease In Vitro Diagnostics
Table 45. Global Infectious Disease In Vitro Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Infectious Disease In Vitro Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Infectious Disease In Vitro Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Infectious Disease In Vitro Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Infectious Disease In Vitro Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Infectious Disease In Vitro Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 51. QIAGEN Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 52. QIAGEN Infectious Disease In Vitro Diagnostics Product Offered
Table 53. QIAGEN Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. QIAGEN Main Business
Table 55. QIAGEN Latest Developments
Table 56. BD Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 57. BD Infectious Disease In Vitro Diagnostics Product Offered
Table 58. BD Main Business
Table 59. BD Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. BD Latest Developments
Table 61. bioM?rieux SA Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 62. bioM?rieux SA Infectious Disease In Vitro Diagnostics Product Offered
Table 63. bioM?rieux SA Main Business
Table 64. bioM?rieux SA Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. bioM?rieux SA Latest Developments
Table 66. F. Hoffmann-La Roche, Ltd. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 67. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Product Offered
Table 68. F. Hoffmann-La Roche, Ltd. Main Business
Table 69. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. F. Hoffmann-La Roche, Ltd. Latest Developments
Table 71. Hologic, Inc. (Gen-Probe) Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 72. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Product Offered
Table 73. Hologic, Inc. (Gen-Probe) Main Business
Table 74. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Hologic, Inc. (Gen-Probe) Latest Developments
Table 76. Abbott Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 77. Abbott Infectious Disease In Vitro Diagnostics Product Offered
Table 78. Abbott Main Business
Table 79. Abbott Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Abbott Latest Developments
Table 81. Quidel Corp. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 82. Quidel Corp. Infectious Disease In Vitro Diagnostics Product Offered
Table 83. Quidel Corp. Main Business
Table 84. Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Quidel Corp. Latest Developments
Table 86. Siemens Healthineers AG Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 87. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Product Offered
Table 88. Siemens Healthineers AG Main Business
Table 89. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Siemens Healthineers AG Latest Developments
Table 91. Bio-Rad Laboratories, Inc. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 92. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Product Offered
Table 93. Bio-Rad Laboratories, Inc. Main Business
Table 94. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bio-Rad Laboratories, Inc. Latest Developments
Table 96. Danaher Corp. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 97. Danaher Corp. Infectious Disease In Vitro Diagnostics Product Offered
Table 98. Danaher Corp. Main Business
Table 99. Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Danaher Corp. Latest Developments
Table 101. OraSure Technologies, Inc. Details, Company Type, Infectious Disease In Vitro Diagnostics Area Served and Its Competitors
Table 102. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Product Offered
Table 103. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. OraSure Technologies, Inc. Main Business
Table 105. OraSure Technologies, Inc. Latest Developments
LIST OF FIGURES
LIST OF FIGURES
Figure 1. Infectious Disease In Vitro Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease In Vitro Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Type in 2021
Figure 7. Infectious Disease In Vitro Diagnostics in Hospitals & Clinics
Figure 8. Global Infectious Disease In Vitro Diagnostics Market: Hospitals & Clinics (2017-2022) & ($ Millions)
Figure 9. Infectious Disease In Vitro Diagnostics in Diagnostic Laboratories
Figure 10. Global Infectious Disease In Vitro Diagnostics Market: Diagnostic Laboratories (2017-2022) & ($ Millions)
Figure 11. Infectious Disease In Vitro Diagnostics in Others
Figure 12. Global Infectious Disease In Vitro Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 14. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Player in 2021
Figure 15. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Infectious Disease In Vitro Diagnostics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Infectious Disease In Vitro Diagnostics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Infectious Disease In Vitro Diagnostics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Infectious Disease In Vitro Diagnostics Value Market Share by Country in 2021
Figure 21. Americas Infectious Disease In Vitro Diagnostics Consumption Market Share by Type in 2021
Figure 22. Americas Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 23. United States Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Region in 2021
Figure 28. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 29. China Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Country in 2021
Figure 36. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Type in 2021
Figure 37. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 38. Germany Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 46. Egypt Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 55. United States Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. China Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. India Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. France Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. UK Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
LIST OF FIGURES
Figure 1. Infectious Disease In Vitro Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease In Vitro Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Type in 2021
Figure 7. Infectious Disease In Vitro Diagnostics in Hospitals & Clinics
Figure 8. Global Infectious Disease In Vitro Diagnostics Market: Hospitals & Clinics (2017-2022) & ($ Millions)
Figure 9. Infectious Disease In Vitro Diagnostics in Diagnostic Laboratories
Figure 10. Global Infectious Disease In Vitro Diagnostics Market: Diagnostic Laboratories (2017-2022) & ($ Millions)
Figure 11. Infectious Disease In Vitro Diagnostics in Others
Figure 12. Global Infectious Disease In Vitro Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 14. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Player in 2021
Figure 15. Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Infectious Disease In Vitro Diagnostics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Infectious Disease In Vitro Diagnostics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Infectious Disease In Vitro Diagnostics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Infectious Disease In Vitro Diagnostics Value Market Share by Country in 2021
Figure 21. Americas Infectious Disease In Vitro Diagnostics Consumption Market Share by Type in 2021
Figure 22. Americas Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 23. United States Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Region in 2021
Figure 28. APAC Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 29. China Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Country in 2021
Figure 36. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Type in 2021
Figure 37. Europe Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 38. Germany Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Market Share by Application in 2021
Figure 46. Egypt Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Infectious Disease In Vitro Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 55. United States Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. China Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. India Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. France Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. UK Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Infectious Disease In Vitro Diagnostics Market Size 2023-2028 ($ Millions)
